![](/img/cover-not-exists.png)
Salvage with erlotinib plus bevacizumab: not in NSCLC
Jean-Paul Sculier, Anne-Pascal Meert, Thierry BerghmansVolume:
377
Year:
2011
Language:
english
DOI:
10.1016/s0140-6736(11)60740-x
File:
PDF, 150 KB
english, 2011